Literature DB >> 23546561

Endoscopic ultrasound in staging esophageal cancer after neoadjuvant chemotherapy--results of a multicenter cohort analysis.

Hauke Sebastian Heinzow1, Hans Seifert, Sven Tsepetonidis, Heiner Wolters, Torsten Kucharzik, Wolfram Domschke, Dirk Domagk, Tobias Meister.   

Abstract

BACKGROUND: Endoscopic ultrasound (EUS) is considered a gold standard in the initial staging of esophageal cancer. There is an ongoing debate whether EUS is useful for tumor staging after neoadjuvant chemotherapy (NAC).
METHODS: Ninety-five patients with esophageal cancer were retrospectively analyzed. In 45 patients, EUS was performed prior to and after NAC, while 50 patients had no induction therapy. Histological correlation through surgery was available. uT/uN classifications were compared to pT/pN stages. Statistical analysis included calculation of sensitivity, specificity, and accuracy rates. Agreement between endosonography and T staging was assessed with Cohen's kappa statistics.
RESULTS: For those patients with prior NAC, overall accuracy of yuT and yuN classification was 29 and 62%, respectively. Sensitivity, specificity, and accuracy rates for local tumor extension after NAC were as follows (%): T1: -/97/84, T2: 13/76/53, T3:86/29/46, T4:20/100/91, T1/2: 27/83/56, T3/4: 89/31/56. Cohen's kappa indicated poor agreement (kappa = 0.129) between yuT classification and ypT stage. Relative to positive lymph node detection, sensitivity and specificity were 100 and 6%, respectively (kappa = 0.06). T stage was overstaged in 23 (51%) and understaged in seven (16%) patients.
CONCLUSION: EUS is an unreliable tool for staging esophageal cancer after NAC. Overstaging of the T stage is common after NAC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546561     DOI: 10.1007/s11605-013-2189-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  35 in total

1.  Effect of surgical experience on results of esophagectomy for esophageal carcinoma.

Authors:  J D Miller; M K Jain; C J de Gara; D Morgan; J D Urschel
Journal:  J Surg Oncol       Date:  1997-05       Impact factor: 3.454

2.  Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.

Authors:  Val J Lowe; Fargol Booya; J G Fletcher; Mark Nathan; Eric Jensen; Brian Mullan; Eric Rohren; Maurits J Wiersema; Enrique Vazquez-Sequeiros; Joseph A Murray; Mark S Allen; Michael J Levy; Jonathan E Clain
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

3.  Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy.

Authors:  E Laterza; G de Manzoni; A Guglielmi; L Rodella; P Tedesco; C Cordiano
Journal:  Ann Thorac Surg       Date:  1999-05       Impact factor: 4.330

4.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

5.  Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment?

Authors:  A Kutup; Y K Vashist; S Groth; E Vettorazzi; E F Yekebas; N Soehendra; J R Izbicki
Journal:  Endoscopy       Date:  2012-04-23       Impact factor: 10.093

6.  Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma.

Authors:  S R Preston; G W B Clark; I G Martin; H M Sue Ling; K M Harris
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

7.  Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly.

Authors:  Julian A Abrams; Donna L Buono; Joshua Strauss; Russell B McBride; Dawn L Hershman; Alfred I Neugut
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

8.  Miniprobe endoscopic ultrasound accurately stages esophageal cancer and guides therapeutic decisions in the era of neoadjuvant therapy: results of a multicenter cohort analysis.

Authors:  Tobias Meister; Hauke Sebastian Heinzow; Regina Osterkamp; Till Wehrmann; Torsten Kucharzik; Wolfram Domschke; Dirk Domagk; Hans Seifert
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

9.  Carcinoma of the esophagus: CT vs MR imaging in determining resectability.

Authors:  S Takashima; N Takeuchi; H Shiozaki; K Kobayashi; S Morimoto; J Ikezoe; N Tomiyama; K Harada; K Shogen; T Kozuka
Journal:  AJR Am J Roentgenol       Date:  1991-02       Impact factor: 3.959

10.  Mortality after esophageal and gastric cancer resection.

Authors:  Ugo Fedeli; Elena Schievano; Manola Lisiero
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

View more
  7 in total

1.  Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer.

Authors:  Wolfram Bohle; Michaela Kasper; Wolfram G Zoller
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

2.  Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes.

Authors:  Michael J McNamara; David J Adelstein; Daniela S Allende; Joanna W Bodmann; Denise I Ives; Sudish C Murthy; Daniel Raymond; Siva Raja; Cristina P Rodriguez; Davendra Sohal; Kevin L Stephans; Gregory M M Videtic; Lisa A Rybicki
Journal:  J Gastrointest Cancer       Date:  2017-06

Review 3.  Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.

Authors:  Lawrence Kleinberg; Malcolm Brock; Michael Gibson
Journal:  Curr Treat Options Oncol       Date:  2015-07

4.  Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences.

Authors:  Kumar K Shashi; Rachna Madan; Mark M Hammer; Steven van Hedent; Suzanne C Byrne; Eric J Schmidlin; Harvey Mamon; Hiroto Hatabu; Peter C Enzinger; Victor H Gerbaudo
Journal:  Eur J Radiol Open       Date:  2020-12-01

5.  Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation.

Authors:  Shohei Yonemoto; Masaya Uesato; Akira Nakano; Kentaro Murakami; Takeshi Toyozumi; Tetsuro Maruyama; Hiroshi Suito; Tomohide Tamachi; Manami Kato; Shunsuke Kainuma; Keisuke Matsusaka; Hisahiro Matsubara
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

6.  FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.

Authors:  Yung-Cheng Huang; Hung-I Lu; Shun-Chen Huang; Chien-Chin Hsu; Nan-Tsing Chiu; Yu-Ming Wang; Yi-Chun Chiu; Shau-Hsuan Li
Journal:  BMC Med Imaging       Date:  2017-01-05       Impact factor: 1.930

7.  Systematic review and meta-analysis of endoscopic ultrasonography in staging diagnosis of esophageal cancer after neoadjuvant radiotherapy and chemotherapy.

Authors:  Xiaodong Li; Yixiao Wang; Min Kong; Jiang Lin
Journal:  J Gastrointest Oncol       Date:  2022-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.